Commerce Bank Increases Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Commerce Bank grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 184.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 53,555 shares of the company's stock after acquiring an additional 34,745 shares during the period. Commerce Bank's holdings in GE HealthCare Technologies were worth $4,187,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of GEHC. Canada Pension Plan Investment Board lifted its holdings in GE HealthCare Technologies by 4.8% during the fourth quarter. Canada Pension Plan Investment Board now owns 2,701,762 shares of the company's stock valued at $211,224,000 after purchasing an additional 124,651 shares during the last quarter. Gratus Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the 4th quarter worth approximately $597,000. Marshall Wace LLP grew its stake in GE HealthCare Technologies by 22.5% in the 4th quarter. Marshall Wace LLP now owns 240,713 shares of the company's stock valued at $18,819,000 after buying an additional 44,180 shares in the last quarter. NewEdge Advisors LLC raised its holdings in GE HealthCare Technologies by 4.2% during the 4th quarter. NewEdge Advisors LLC now owns 17,907 shares of the company's stock valued at $1,400,000 after acquiring an additional 715 shares during the period. Finally, Jump Financial LLC boosted its holdings in shares of GE HealthCare Technologies by 15.3% in the fourth quarter. Jump Financial LLC now owns 8,740 shares of the company's stock worth $683,000 after acquiring an additional 1,163 shares during the period. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Trading Up 2.0 %

GE HealthCare Technologies stock traded up $1.34 during trading hours on Friday, reaching $68.42. The stock had a trading volume of 5,508,561 shares, compared to its average volume of 3,258,512. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a fifty day simple moving average of $76.59 and a 200-day simple moving average of $82.19. The stock has a market cap of $31.33 billion, a PE ratio of 15.80, a PEG ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.20%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's payout ratio is presently 3.23%.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of recent research reports. Piper Sandler dropped their price objective on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a report on Wednesday. Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the company a "buy" rating in a report on Monday, April 14th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $96.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.